封面
市场调查报告书
商品编码
1612827

透明质酸皮肤填充剂的全球市场:产业分析,规模,占有率,成长,趋势,预测(2024年~2031年)

Hyaluronic Acid Based Dermal Fillers Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

出版日期: | 出版商: Persistence Market Research | 英文 192 Pages | 商品交期: 2-5个工作天内

价格
简介目录

2024年全球透明质酸真皮填充剂市场规模预估为48亿美元,2024-2031年预测期间复合年增长率为7.8%,到2031年将达到81亿美元。

基于透明质酸的真皮填充剂是非永久性注射疗法,用于透过补充流失的透明质酸来减少皱纹、恢復体积和增强面部特征。这些真皮填充剂在美容手术中广泛流行,因为它们提供了一种微创解决方案,具有自然的外观。由于对美容、抗衰老解决方案和脸部年轻化手术的需求不断增加,这些填充剂的市场正在迅速扩大。此外,人们对美容治疗的认识和接受度不断提高正在推动全球市场的成长。

全球透明质酸真皮填充剂市场受到多种因素的推动,包括对非侵入性美容手术(尤其是脸部年轻化)日益增长的需求。世界老化人口的成长是一个主要推动因素,需要解决方案来减少明显的老化迹象。此外,透明质酸填充剂技术的进步提供了更持久的效果并提高了安全性,有助于市场扩张。微创治疗的日益普及,加上透明质酸填充剂的便利性和有效性,正在吸引更多的人接受这些手术。此外,针对不同皮肤类型推出不同配方的新产品正在创造新的市场机会。

由于新兴市场对微创整容手术的需求不断增长,该市场提供了巨大的成长机会。随着亚太和拉丁美洲等地区可支配收入的增加,越来越多的人选择整容手术,从而产生了对透明质酸真皮填充剂的需求。透明质酸交联和生物刺激技术等先进技术的整合有望提高真皮填充剂的效果和安全性,从而吸引更大的客户群。此外,与护肤品牌的合作以及加强消费者对透明质酸真皮填充剂益处的教育是市场参与者扩大影响力的关键机会。

本报告提供全球透明质酸皮肤填充剂市场相关调查,提供各产品类型,各用途,各最终用途,各地区趋势,及加入此市场的主要企业简介等资讯。

目录

第1章 摘要整理

第2章 市场概要

  • 市场范围和定义
  • 市场动态
  • 宏观经济要素
  • COVID-19影响分析
  • 预测要素- 相关性及影响

第3章 附加价值的洞察

  • 产品类型的招聘分析
  • 法规情形
  • 价值链分析
  • 主要的交易合併
  • 大环境分析
  • 波特的五力分析

第4章 透明质酸皮肤填充剂市场预测:实际成果(2019年~2023年)及预测(2024年~2031年)

  • 主要的焦点
  • 市场规模(10亿美元)分析与预测
  • 透明质酸皮肤填充剂市场预测:各产品类型
  • 透明质酸皮肤填充剂市场预测:各用途
  • 透明质酸皮肤填充剂市场预测:各最终用途

第5章 透明质酸皮肤填充剂市场预测:各地区

  • 主要的焦点
  • 过去的市场规模(10亿美元)的分析,各地区,2019年~2023年
  • 目前市场规模(10亿美元)的分析与预测,各地区,2024年~2031年
  • 市场魅力分析:各地区

第6章 北美的透明质酸皮肤填充剂市场预测:实际成果(2019年~2023年)及预测(2024年~2031年)

第7章 欧洲的透明质酸皮肤填充剂市场预测:过去(2019-2023)及预测(2024-2031)

第8章 东亚的透明质酸皮肤填充剂市场预测:实际成果(2019年~2023年)及预测(2024年~2031年)

第9章 南亚及大洋洲的透明质酸皮肤填充剂市场预测:实际成果(2019年~2023年)及预测(2024年~2031年)

第10章 南美的透明质酸皮肤填充剂市场预测:实际成果(2019年~2023年)及预测(2024年~2031年)

第11章 中东·非洲的透明质酸皮肤填充剂市场预测:实际成果(2019年~2023年)及预测(2024年~2031年)

第12章 竞争情形

  • 市场占有率分析,2024年
  • 市场结构
  • 企业简介(详细内容- 概要,财务,策略,最近的趋势)
    • Allergan Aesthetics (AbbVie Inc.)
    • Galderma
    • Anika Therapeutics Inc.
    • Merz Pharmaceuticals
    • Genzyme Corporation
    • Bio plus Co. Ltd.
    • LG Life Sciences
    • Sinclair Pharma
    • Sculpt Luxury
    • Dermal Fillers Ltd.
    • Bioxis Pharmaceutical
    • Sinclair Pharma; Laboratories
    • Bohus BioTech AB

第13章 附录

简介目录
Product Code: PMRREP34953

Persistence Market Research has recently released a comprehensive report on the global market for Hyaluronic Acid Based Dermal Fillers. This report provides an in-depth analysis of the key market dynamics, including growth drivers, trends, opportunities, and challenges, offering valuable insights into the market structure. The publication also presents exclusive data and forecasts that outline the expected growth trajectory of the global Hyaluronic Acid Based Dermal Fillers Market from 2024 to 2031.

Key Insights:

  • Hyaluronic Acid Based Dermal Fillers Market Size (2024E): US$ 4.8 Bn
  • Projected Market Value (2031F): US$ 8.1 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 7.8%

Hyaluronic Acid Based Dermal Fillers Market - Report Scope:

Hyaluronic acid-based dermal fillers are non-permanent injectable treatments used to reduce wrinkles, restore volume, and enhance facial features by replenishing lost hyaluronic acid. These dermal fillers are widely popular in aesthetic procedures, as they provide a minimally invasive solution with natural-looking results. The market for these fillers is rapidly expanding due to the rising demand for cosmetic enhancements, anti-aging solutions, and facial rejuvenation procedures. Additionally, growing awareness and acceptance of aesthetic treatments are fueling market growth globally.

Market Growth Drivers:

The global Hyaluronic Acid Based Dermal Fillers market is propelled by several factors, including the increasing desire for non-invasive cosmetic procedures, particularly for facial rejuvenation. The growing aging population worldwide is a key driver, as individuals seek solutions to reduce the visible signs of aging. Furthermore, the advancements in hyaluronic acid filler technology, which offer longer-lasting results and increased safety profiles, are contributing to market expansion. The rising popularity of minimally invasive treatments, combined with the convenience and effectiveness of hyaluronic acid-based fillers, is attracting more individuals to undergo these procedures. Additionally, the availability of new product variants with different formulations for various skin types is opening up new market opportunities.

Market Restraints:

Despite strong growth prospects, the market faces challenges related to the high cost of treatments and the potential side effects of dermal fillers, such as bruising, swelling, and allergic reactions. The need for skilled professionals to administer these treatments also limits accessibility in certain regions, especially in developing economies. Moreover, the lack of standardization in the hyaluronic acid filler market, along with concerns over counterfeit products, poses a challenge for industry growth. Regulatory hurdles and the potential for complications related to the use of dermal fillers may also hinder the market's expansion.

Market Opportunities:

The market presents significant growth opportunities driven by the increasing demand for minimally invasive cosmetic procedures in emerging markets. As disposable income rises in regions like Asia Pacific and Latin America, more individuals are opting for cosmetic enhancements, creating a demand for hyaluronic acid-based dermal fillers. The integration of advanced technologies such as hyaluronic acid crosslinking and bio-stimulation techniques is expected to enhance the results and safety of dermal fillers, thereby attracting a larger customer base. Furthermore, collaborations with skincare brands and expanding consumer education on the benefits of hyaluronic acid dermal fillers are key opportunities for market players to grow their presence.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Hyaluronic Acid Based Dermal Fillers market?
  • How are advancements in hyaluronic acid technology influencing the market dynamics?
  • Who are the major players in the market, and what strategies are they employing to maintain their competitive advantage?
  • What are the emerging trends in the global Hyaluronic Acid Based Dermal Fillers market, and what is the future outlook?
  • How are market players addressing challenges related to safety, regulation, and product quality?

Competitive Intelligence and Business Strategy:

Leading companies in the global Hyaluronic Acid Based Dermal Fillers market, including Allergan (AbbVie Inc.), Revance Therapeutics, Inc., Galderma S.A., Ipsen Pharma, and Medytox Inc., focus on product innovation and expanding their portfolios of hyaluronic acid-based fillers. These companies invest heavily in research and development to improve the safety, effectiveness, and longevity of their products. Additionally, strategic partnerships and collaborations with aesthetic clinics and professionals are helping them expand their market share. Brand awareness campaigns, customer education programs, and the launch of new product variants targeting different age groups and skin types are also key strategies employed by leading players.

Key Companies Profiled:

  • Allergan Aesthetics (AbbVie Inc.)
  • Galderma
  • Anika Therapeutics Inc.
  • Merz Pharmaceuticals
  • Genzyme Corporation
  • Bio plus Co. Ltd.
  • LG Life Sciences
  • Sinclair Pharma
  • Sculpt Luxury
  • Dermal Fillers Ltd.
  • Bioxis Pharmaceutical
  • Sinclair Pharma; Laboratories
  • Bohus BioTech AB

Market Segmentation

By Product Type

  • Single Phase Products
  • Duplex Products

By Application

  • Wrinkle Removal
  • Lip Augmentation
  • Rhinoplasty
  • Others

By End User

  • Specialty and Dermatology Clinics
  • Hospitals and Clinics
  • Others

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • The Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Hyaluronic Acid Based Dermal Fillers Market Snapshot, 2024 - 2031
  • 1.2. Market Opportunity Assessment, 2024 - 2031, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
    • 2.3.3. Global Healthcare Spending Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Type Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
    • 3.3.1. List of Distribution Channel/Marketplaces
      • 3.3.1.1. Retail
      • 3.3.1.2. Audiology
      • 3.3.1.3. E-Commerce
    • 3.3.2. List of End User (Industry)
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Hyaluronic Acid Based Dermal Fillers Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019 - 2023
    • 4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2024 - 2031
  • 4.3. Hyaluronic Acid Based Dermal Fillers Market Outlook: Product Type
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Product Type, 2019 - 2023
    • 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
      • 4.3.3.1. Single Phase Products
      • 4.3.3.2. Duplex Products
    • 4.3.4. Market Attractiveness Analysis: Product Type
  • 4.4. Hyaluronic Acid Based Dermal Fillers Market Outlook: Application
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019 - 2023
    • 4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
      • 4.4.3.1. Wrinkle Removal
      • 4.4.3.2. Lip Augmentation
      • 4.4.3.3. Rhinoplasty
      • 4.4.3.4. Others
    • 4.4.4. Market Attractiveness Analysis: Application
  • 4.5. Hyaluronic Acid Based Dermal Fillers Market Outlook: End-use
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Bn) Analysis, By End-use, 2019 - 2023
    • 4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2024 - 2031
      • 4.5.3.1. Specialty & Dermatology Clinics
      • 4.5.3.2. Hospitals & Clinics
      • 4.5.3.3. Others
    • 4.5.4. Market Attractiveness Analysis: End-use

5. Hyaluronic Acid Based Dermal Fillers Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019 - 2023
  • 5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2024 - 2031
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Hyaluronic Acid Based Dermal Fillers Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 6.2.1. By Country
    • 6.2.2. By Product Type
    • 6.2.3. By Application
    • 6.2.4. By End-use
  • 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
    • 6.4.1. Single Phase Products
    • 6.4.2. Duplex Products
  • 6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 6.5.1. Wrinkle Removal
    • 6.5.2. Lip Augmentation
    • 6.5.3. Rhinoplasty
    • 6.5.4. Others
  • 6.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2024 - 2031
    • 6.6.1. Specialty & Dermatology Clinics
    • 6.6.2. Hospitals & Clinics
    • 6.6.3. Others
  • 6.7. Market Attractiveness Analysis

7. Europe Hyaluronic Acid Based Dermal Fillers Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 7.2.1. By Country
    • 7.2.2. By Product Type
    • 7.2.3. By Application
    • 7.2.4. By End-use
  • 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
    • 7.4.1. Single Phase Products
    • 7.4.2. Duplex Products
  • 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 7.5.1. Wrinkle Removal
    • 7.5.2. Lip Augmentation
    • 7.5.3. Rhinoplasty
    • 7.5.4. Others
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2024 - 2031
    • 7.6.1. Specialty & Dermatology Clinics
    • 7.6.2. Hospitals & Clinics
    • 7.6.3. Others
  • 7.7. Market Attractiveness Analysis

8. East Asia Hyaluronic Acid Based Dermal Fillers Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 8.2.1. By Country
    • 8.2.2. By Product Type
    • 8.2.3. By Application
    • 8.2.4. By End-use
  • 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
    • 8.4.1. Single Phase Products
    • 8.4.2. Duplex Products
  • 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 8.5.1. Wrinkle Removal
    • 8.5.2. Lip Augmentation
    • 8.5.3. Rhinoplasty
    • 8.5.4. Others
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2024 - 2031
    • 8.6.1. Specialty & Dermatology Clinics
    • 8.6.2. Hospitals & Clinics
    • 8.6.3. Others
  • 8.7. Market Attractiveness Analysis

9. South Asia & Oceania Hyaluronic Acid Based Dermal Fillers Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 9.2.1. By Country
    • 9.2.2. By Product Type
    • 9.2.3. By Application
    • 9.2.4. By End-use
  • 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
    • 9.4.1. Single Phase Products
    • 9.4.2. Duplex Products
  • 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 9.5.1. Wrinkle Removal
    • 9.5.2. Lip Augmentation
    • 9.5.3. Rhinoplasty
    • 9.5.4. Others
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2024 - 2031
    • 9.6.1. Specialty & Dermatology Clinics
    • 9.6.2. Hospitals & Clinics
    • 9.6.3. Others
  • 9.7. Market Attractiveness Analysis

10. Latin America Hyaluronic Acid Based Dermal Fillers Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 10.2.1. By Country
    • 10.2.2. By Product Type
    • 10.2.3. By Application
    • 10.2.4. BY End-use
  • 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
    • 10.4.1. Single Phase Products
    • 10.4.2. Duplex Products
  • 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 10.5.1. Wrinkle Removal
    • 10.5.2. Lip Augmentation
    • 10.5.3. Rhinoplasty
    • 10.5.4. Others
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2024 - 2031
    • 10.6.1. Specialty & Dermatology Clinics
    • 10.6.2. Hospitals & Clinics
    • 10.6.3. Others
  • 10.7. Market Attractiveness Analysis

11. Middle East & Africa Hyaluronic Acid Based Dermal Fillers Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 11.2.1. By Country
    • 11.2.2. By Product Type
    • 11.2.3. By Application
    • 11.2.4. By End-use
  • 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024 - 2031
    • 11.4.1. Single Phase Products
    • 11.4.2. Duplex Products
  • 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 11.5.1. Wrinkle Removal
    • 11.5.2. Lip Augmentation
    • 11.5.3. Rhinoplasty
    • 11.5.4. Others
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2024 - 2031
    • 11.6.1. Specialty & Dermatology Clinics
    • 11.6.2. Hospitals & Clinics
    • 11.6.3. Others
  • 11.7. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2024
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Allergan Aesthetics (AbbVie Inc.)
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Product Types
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Galderma
    • 12.3.3. Anika Therapeutics Inc.
    • 12.3.4. Merz Pharmaceuticals
    • 12.3.5. Genzyme Corporation
    • 12.3.6. Bio plus Co. Ltd.
    • 12.3.7. LG Life Sciences
    • 12.3.8. Sinclair Pharma
    • 12.3.9. Sculpt Luxury
    • 12.3.10. Dermal Fillers Ltd.
    • 12.3.11. Bioxis Pharmaceutical
    • 12.3.12. Sinclair Pharma; Laboratories
    • 12.3.13. Bohus BioTech AB

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations